ACCEL RESEARCH SITE - Birmingham Clinical Research Unit

A leader in clinical trials for over 10 years, Accel Research Site - Birmingham is a privately-owned, multi-specialty research facility based in the center of Birmingham’s renowned medical community.

Accel Research Sites are industry-leading clinical research sites with the clinical expertise, therapeutic experience and capabilities to successfully fulfill clinical trials in a wide range of therapeutic indications. We pride ourselves on delivering high quality work to our customers, which include major pharmaceuticals, biotech start-ups, and all leading Contract Research Organizations. We conduct Phase I, In-Hospital, Vaccine and Outpatient Phase II-IV trials.

Speed to delivery, a dedicated in-house patient recruitment team, disciplined process management and quality data collection ensure our sponsors receive the highest value for their clinical research investments.


Melissa Hodges, CCRC, CCRP
VP, Clinical Operations & Compliance

Melissa Nichols, CCMA, CCRC
Director of Clinical Operations


Achieve has conducted Phase II-IV studies in many diverse indications, including:
  • Allergy
  • Anesthesia and sedation
  • Anticoagulants
  • Anti-infectives
  • Asthmas
  • Contraception
  • Contrast imaging studies
  • COPD
  • Devices
  • Diabetes
  • Fibromyalgia
  • GERD
  • Gout
  • Healthy Normal
  • Herpes Simplex
  • Hypercholesterolemia
  • Hyperlipidemia
  • Hypertension (including ABPM)
  • Influenza
  • Iron deficiency anemia
  • Irritable bowel syndrome (IBS)
  • Joint relacements (knee, hip)
  • Lupus
  • Migraine
  • Obesity
  • Osteoarthritis
  • Pain, acute and chronic
  • Pharmacodynamics
  • Pharmacokinetics
  • Post-herpetic neuralgia
  • Post-surgical ileus
  • Post-surgical pain
  • Psoriatic Arthritis
  • Psychiatric indications, including depression
  • Rheumatoid Arthritis
  • Sinusitis
  • Sports Injuries, acute
  • Surgery (Orthopaedic, spinal, cosmetic, pain and general)
We are built on a foundation of experienced investigators and staff. We are able to adapt to client requests and protocol requirements while still ensuring accuracy, integrity, and patient safety. We are able to launch and to finish trials quickly and efficiently with our integrated, centralized processes of contracting, IRB submission and study management. Our ultimate goal is to provide our clients with the highest quality data in order to accelerate the availability of marketable drug therapies. Achieve has the experience and staffing necessary to successfully handle complex and process-intensive Phase II-IV clinical trials across multiple indications and specialties, vaccines, rheumatology, surgery and other in-hospital indications.


  • Dedicated research physicians on site
  • Experienced clinical research coordinators and nurses
  • Certified laboratory staff
  • Regulatory specialist
  • Quality assurance department
  • Contracts and budget specialist
  • Full-time patient recruiters with bilingual staff
  • Full-time marketing and advertising department
  • Experiened data entry coordinators


Hayes T. Williams, MD, PhD
Medical Director 

Gary Boyd, MD
Board Certified in Internal Medicine



  • 6 fully-equipped examination rooms
  • Monitor rooms with access to high speed internet
  • Biological safety hood
  • Refrigerated centrifuge
  • -20 and -70 freezers
  • Pulmonary Function Testing
  • CLIA Certified Lab
  • EKG Machines
  • Crash Cart with Defibrillator, ACLS Certified Staff
  • Secure Drug Storage, Both Ambient and Refrigerated
  • Pulse Oximetry
  • Access to free standing radiology and diagnostic services, including MRIs, CTs, XRAYs
  • Convenient access to hospital-based radiology and diagnostic services, including CTs, MRIs, PET scans, ultrasounds, endoscopies and colonoscopies

Achieve Clinical Research, LLC
2017 Canyon Road, Suite 41
Birmingham, Alabama 35216
Telephone: 205-757-8212 ext 441             

Call us: (843) 607-2933  |  email us:  |  follow us:    
Company            Investigator Sites            Therapeutic Expertise            Services            Phase I - IV            Library            News & Events            Contact